Sen’s Research, Vision Position Indiana to Lead Regenerative Medicine

Posted: Updated:
Sen is developing a promising technology that reprograms skin tissue to assume the functionality of tissues or organs that are no longer working properly. Sen is developing a promising technology that reprograms skin tissue to assume the functionality of tissues or organs that are no longer working properly.

Regenerative medicine has “crossed the chasm of impossible to possible,” says a nationally-renowned expert who is leading the charge in Indiana to trailblaze the “new horizon in medicine.” Indiana University School of Medicine (IUSM) Associate Vice President of Research Dr. Chandan Sen believes the new frontier will dominate the practice of medicine within a decade. Sen asserts “somewhere in the world [regenerative medicine] will succeed”—and he believes the steady march forward in his research, combined with the state’s “fertile ground,” make Indiana a contender.

“Over 150 years ago, pills came into medicine, less than 100 years ago…devices came into medicine, and now, we have a new platform coming into medicine,” says Sen. “It’s not pills, not devices, but—for lack of a better expression—it’s body parts that will be made and plugged back into the living body.”

As a result of aging, disease or trauma, organs and tissues lose function; regenerative medicine is the process of creating living, healthy tissues to recover those functions. Sen—whose recruitment was supported by the INCITE program--is among the nation’s leading experts in the cell-based therapy. Less than a year ago, he left The Ohio State University to be the inaugural director of IUSM’s $20 million Indiana Center for Regenerative Medicine and Engineering.

Sen relocated his team of more than 30 scientists and staff to Indiana—a rare move in academics and unprecedented at the university—to continue his groundbreaking research in the emergent field. Among his many research endeavors is a promising technology that converts skin tissue into entirely different kinds of tissue that assume the functionality of tissues or organs that are no longer working properly.

“For example, [a patient] has lost or mangled blood vessels due to trauma, so part of the body is not receiving blood supply,” says Sen. “We have found an approach to convert your own skin—not the blood vessels of your skin—but the skin tissue into blood vessels, which then carry blood into the affected site. We call that in vivo reprogramming.”

The non-invasive, nanochip device works with a simple touch and electric spark that is harmless to the human body. Sen says the licensed technology could ultimately help prevent amputations in diabetics and repair nerve damage due to neuropathy, among other applications.

A second area of his research involves disrupting the vicious cycle of antibiotic resistance: scientists develop new antibiotics that, in turn, generate resistant bacteria. Sen’s method relies, instead, on a “physical approach”—specifically, using an electric field to disrupt infection.

Acknowledging that he was “happily anchored” at Ohio State, Sen says IU Health’s commitment to moving discoveries from the laboratory to patients enticed him to Indiana.

“That’s a risk—in the sense of a business risk. To have the element of uncertainty come into your business model—a lot of people are scared of that. Here, it looks like they have the appetite. That’s a huge draw,” says Sen. “Secondly, across the state of Indiana, you have numerous, quite successful life sciences businesses that are willing to work together as one network, and I see a lot of promise. We scientists can only take our product from imagination to some level of realization. But from realization…to productization, commercialization and then implementation, it requires a large number of people—really, a pipeline of talent and infrastructure that seem to be rapidly developing here in Indiana.” 

Sen cautions that regenerative medicine is not without significant challenges. Science, and the public in general, are familiar with drugs, devices and vaccines, but engineering living tissue to “plug back into the body” is a paradigm shift in biology, healthcare and society. The new frontier will demand changes in training; for example, IUSM is developing the nation’s first master’s and PhD program in regenerative medicine and engineering.

Sen says regenerative medicine will also require throwing out old molds for funding and engaging the public with “town hall-type meetings.”

“You’re recreating a part of—if I may exaggerate a little—human civilization by digging into this very new dimension that isn’t about a particular disease or solution, but a new paradigm,” says Sen. “There’s no question regenerative medicine will be successful. Whether Indiana will play a major role in that—that’s the question, and the answer needs to be yes.”  

Sen says regenerative medicine recognizes the body as an “engineering marvel” that will demand experts in a variety of fields.
Sen says the disruptive nature of regenerative medicine requires engaging tomorrow’s workforce “at the ground level” and creating new structures for funding.
Sen says Indiana has the ingredients to move discoveries to the patient’s bedside.
  • Perspectives

    • (photo courtesy of Conexus)

      October Celebrates Indiana’s Vibrant Manufacturing Industry

      Indiana is the most manufacturing intensive state in the country and more than a third of the state’s GDP comes from the industry. The health and wellness of Indiana’s economy is dependent on the state’s manufacturing industry. But Hoosiers face a challenge: it is expected that nearly a quarter of the current manufacturing workforce will be of retirement age in the next 10 years and we lack the generational workforce to make up that gap.

    More

Subscribe

Name:
Company Name:
Email:
Confirm Email:
HTML
INside Edge
Morning Briefing
BigWigs & New Gigs
Life Sciences Indiana
Indiana Connections
INPower
Subscribe
Unsubscribe

Events



  • Most Popular Stories

    • Regal Beloit is closing in Valparaiso. (photo courtesy; The Times of Northwest Indiana)

      Valpo Bearings Plant to Close, Eliminating 160+ Jobs

      Wisconsin-based Regal Beloit Corp. and the union representing workers have reached an agreement about the closing of a helicopter bearing factory in Valparaiso. According to our partners at The Times of Northwest Indiana, the decision will cost between 160 to 170 workers their jobs. 

    • (image courtesy of The Times of Northwest Indiana)

      U.S. Steel Updates Layoff Notice to State

      Pittsburgh-based U.S. Steel Corp. (NYSE: X) has updated the State of Indiana regarding its previously announced layoffs at the East Chicago Tin Mill. The company says 314, rather than 307, workers will be displaced when the mill is idled this fall. 

    • The Columbian Home Products plant was built in Terre Haute in 1902.

      Kitchenware Maker to Close in Terre Haute

      Illinois-based Columbian Home Products LLC has sent a letter to the State of Indiana saying it intends to close its plant in Terre Haute and lay off 82 workers. According to the WARN letter sent to the Indiana Department of Workforce Development, the layoffs will begin on December 1. 

    • The Lawn at White River State Park currently hosts concerts, but is not a permanent venue. (photo courtesy White River State Park)

      White River Park to Break Ground on Permanent Venue

      White River State Park in Indianapolis will Wednesday host a ground-breaking ceremony for a permanent concert venue on its concert lawn. The project, announced early last year, will include a permanent st...

    • Ingram Micro has more than 170 facilities throughout the world.

      Ingram Micro to Make Announcement

      Officials in Plainfield are set to make another economic development announcement Wednesday morning. Few details are available, however the Indiana Economic Development Corp. says executives from California-based Ingram Micro will take part in the announcement.